INJEX Pharma AG Received FDA Clearance for the Import and Sale of the Needle Free Injection Technology INJEX 30 Into the US Market

BERLIN--(BUSINESS WIRE)--The FDA had registered INJEX Pharma GmbH, Berlin, and INJEX Pharma US, Miami, and given approval for the import and sale of INJEX 30 in the US market. The condition was the registration by the FDA for INJEX Pharma GmbH as manufacturer and exporter. This registration is now finalized.

MORE ON THIS TOPIC